The incidence and risk factors for acute kidney injury in patients treated with immune checkpoint inhibitors.

MLA

Guven, Deniz Can, et al. “The Incidence and Risk Factors for Acute Kidney Injury in Patients Treated with Immune Checkpoint Inhibitors.” Anti-Cancer Drugs, vol. 34, no. 6, July 2023, pp. 783–90. EBSCOhost, https://doi.org/10.1097/CAD.0000000000001463.

APA

Guven, D. C., Ozbek, D. A., Sahin, T. K., Kavgaci, G., Aksun, M. S., Erul, E., Yildirim, H. C., Chalabiyev, E., Cebroyilov, C., Yildirim, T., Dizdar, O., Aksoy, S., Yalcin, S., Kilickap, S., Erman, M., & Arici, M. (2023). The incidence and risk factors for acute kidney injury in patients treated with immune checkpoint inhibitors. Anti-Cancer Drugs, 34(6), 783–790. https://doi.org/10.1097/CAD.0000000000001463

Chicago

Guven, Deniz Can, Deniz Aral Ozbek, Taha Koray Sahin, Gozde Kavgaci, Melek Seren Aksun, Enes Erul, Hasan Cagri Yildirim, et al. 2023. “The Incidence and Risk Factors for Acute Kidney Injury in Patients Treated with Immune Checkpoint Inhibitors.” Anti-Cancer Drugs 34 (6): 783–90. doi:10.1097/CAD.0000000000001463.